U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774455) titled 'Pacritinib Effectiveness in Real-world Settings' on July 22.
Brief Summary: This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Myelofibrosis (MF)
Intervention:
OTHER: Not applicable- observational study
Not Applicable - Observational Study
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Swedish Orphan Biovitrum
Disclaimer: Curated by HT Syndication....